Skip to main content

Table 3 Follow-up methodologies in RCTs according to the date of beginning of patients enrollment

From: Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

 

Date of beginning of patients enrollment

Before 1998

After 1998

Follow-up approach

Follow-up approach

Minimal

Intensive

 

Minimal

Intensive

 

No. (%)

No. (%)

P value

No. (%)

No. (%)

P value

Geographic location

    

International

7 (87)

1 (13)

 

5 (100)

-

0.01

North America (USA and Canada)

3 (60)

2 (40)

 

4 (80)

1 (20)

 

Western Europe

12 (37)

20 (63)

 

1 (16)

5 (83)

 

East Asia (Japan, Vietnam, China)

1 (33)

2 (67)

0.07

-

2 (100)

 

Number of participating countries

    

1 country

13 (39)

20 (60)

 

3 (30)

7 (70)

0.01

> 1 country

10 (66)

5 (33)

0.08

7 (87)

1 (87)

 

Number of participating centers

    

≤ 50

11 (46)

13 (54)

 

-

5 (100.0)

0.02

> 50

6 (54)

5 (46)

0.63

4 (67)

2 (33)

 

Industry sponsorship

    

Yes

9 (41)

13 (59)

 

9 (60)

6 (40)

0.40

No

14 (54)

12 (46)

0.37

1 (33)

2 (67)

 

Number of enrolled patients

    

≤ 1000 patients

13 (45)

16 (55)

 

1 (20.0)

4 (80.0)

0.06

> 1000 patients

10 (53)

9 (47)

0.60

9 (69)

4 (31)